CO-EVOLVED MOLECULES

View On IPO.GOV.AU

Protected: Registered/protected

Last updated on 13 Jan 2022

Owner Info

Empress Therapeutics, Inc.

55 Cambridge Parkway, Suite 800E

Cambridge MA 02142, UNITED STATES OF AMERICA

Serial Number

2223795 filed on 22 Sept 2021

Correspondent

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.

600 Atlantic Avenue,

Boston MA 02110,

UNITED STATES OF AMERICA

CO-EVOLVED MOLECULES

Classification Information

2223795

22 Sept 2021

22 Sept 2031

WORD

26 Mar 2021

Status Date	Action Taken
13^th Jan 2022	International Registration in Australia Protected correspondence sent
12^th Jan 2022	IP Right Registration Published
12^th Jan 2022	Status change to Registered/Protected
6^th Nov 2021	Application Accepted correspondence sent
5^th Nov 2021	IP Right has been Examined
5^th Nov 2021	IP Right Acceptance Published
5^th Nov 2021	Status change to Accepted
1^st Nov 2021	Awaiting examination
1^st Nov 2021	Examination expedited
28^th Oct 2021	IP Right Filed Published